trial · primary record
tilrekimig
Asthma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1100 |
| Primary completion | 2029-08-24 |
| Primary endpoint | Annualized asthma exacerbation rate over 52 weeks |
| Registry ID | NCT07772921 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:03.427Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07772921
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.